Quest Diagnostics (NY:DGX)

245.62 +3.06 (+1.26%)

Official Closing Price Updated: 7:00 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Earnings Scheduled For July 22, 2021 ↗

July 22, 2021

Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is estimated to report earnings for its fourth quarter. • MarineMax,...

Via Benzinga

Earnings Preview: Quest Diagnostics ↗

July 21, 2021

On Thursday, July 22, Quest Diagnostics (NYSE:DGX) will release its latest earnings report. Benzinga's outlook for Quest Diagnostics is included in the following report. What Are...

Via Benzinga

Quest Diagnostics's Earnings: A Preview ↗

July 21, 2021

Quest Diagnostics (NYSE:DGX) will be releasing its next round of earnings this Thursday, July 22. For all of the relevant information, here is your guide for Thursday's Q2...

Via Benzinga

The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs ↗

July 18, 2021

Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears,...

Via Talk Markets

The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs ↗

July 18, 2021

Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week...

Via Benzinga

Understanding Quest Diagnostics's Ex-Dividend Date ↗

July 02, 2021

On May 20, 2021, Quest Diagnostics (NYSE:DGX) announced shar...

Via Benzinga

Quest Diagnostics Keeps Slumping, Here’s The Trade ↗

June 08, 2021

Quest Diagnostics Inc stock has excellent support around the $118.00 level. This support area is where the stock broke out to the upside back in March 2021.

Via Talk Markets

Stocks That Hit 52-Week Highs On Monday ↗

May 10, 2021

This morning 792 companies reached new 52-week highs. Points of Interest: JPMorgan Chase (NYSE: JPM) was the largest company by market cap to set a new 52-week high. The...

Via Benzinga

30 Firms Going Ex-Dividend Next Week, Including AT&T, Comcast And Verizon Communications ↗

July 04, 2021

There are several well known large cap stocks going ex-dividend next week including six Top 100 Dividend Stocks: Sempra Energy, Quest Diagnostics, Comcast, AT&T, Verizon Communications and Hormel...

Via Talk Markets

Lots Of Bearish Sentiment Toward Quest Diagnostics, And That Could Help The Stock Move Higher ↗

June 29, 2021

Quest Diagnostics has been trending higher for the last 16 months and a trend channel has formed that helps define the different cycles within the overall trend. Analysts and short sellers are...

Via Talk Markets

Quest Diagnostics Releases Annual Corporate Responsibility Report

June 23, 2021

SOURCE: 3BL Alerts

Via 3BL Media

Biocept Stock Moves Higher On Collaboration With Quest Diagnostics For Liquid Biopsy Testing For Lung Cancer Patients ↗

June 22, 2021

Biocept Inc (NASDAQ: BIOC) has collaborated with Quest Diagnostics Inc (NYSE: DGX) to provide laboratory testing services to Quest patients for its Target...

Via Benzinga

Biocept to Collaborate with Quest Diagnostics to Provide Advanced NGS-Based Liquid Biopsy Testing for Patients with Lung Cancer

June 22, 2021

From Biocept, Inc.

Via Business Wire

2 Incredibly Cheap Healthcare Stocks ↗

June 18, 2021

These companies dominate a vital medical industry niche, and their valuations are near their all-time lows.

Via The Motley Fool

The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗

June 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

June 14, 2021

What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

June 07, 2021

What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

IBD Rating Upgrades: Laboratory Corporation Of America Key Stock Rating Climbs Amid 279% Profit Growth On 47% Sales Surge ↗

June 03, 2021

The 73 RS Rating means Labcorp has outperformed 73% of all stocks over the past year. It's good but not great. However, other key ratings are outstanding.

Via Investor's Business Daily

Agiliti Stock Clears Key Benchmark, Hitting 80-Plus RS Rating ↗

June 01, 2021

Agiliti stock had its Relative Strength Rating upgraded from 80 to 85 Tuesday. An RS Rating over the key 80 benchmark makes Agiliti a stock to watch.

Via Investor's Business Daily

Social & Health Research Center and Quest Diagnostics Team Up to Address Childhood Hunger and Obesity Exacerbated by COVID-19 in Underserved Communities

May 24, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Topics Economy

10 Biggest Price Target Changes For Tuesday ↗

May 04, 2021

Bernstein lifted the price target on The Boeing Company (NYSE: BA) from $196 to $229. Boeing shares rose 0.5% to $236.39 in pre-market trading. Goldman Sachs cut The Kroger Co...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗

May 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...

Via Benzinga

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗

May 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2021 ↗

May 04, 2021

Upgrades For Genuine Parts Co (NYSE:GPC), Goldman Sachs upgraded the previous rating of Sell to Neutral. In the first quarter, Genuine Parts showed an EPS of $1.50,...

Via Benzinga

Quest Diagnostics Inc (DGX) Q1 2021 Earnings Call Transcript ↗

April 22, 2021

DGX earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Recap: Quest Diagnostics Q1 Earnings ↗

April 22, 2021

Shares of Quest Diagnostics (NYSE:DGX) rose 0.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 300.00% year...

Via Benzinga

The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data ↗

May 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs ↗

April 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.